1. India Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Genpharmasec Ltd.

Genpharmasec Ltd.

GENPHARMA.BO
Genpharmasec Ltd.IN flagBombay Stock Exchange
1.13
INR
+0.02
- -
625.70MMarket Cap

Total Valuation

Genpharmasec Ltd. carries a market capitalization of 625.70M, placing it among publicly traded companies globally. Its enterprise value stands at 693.50M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap625.70M
Enterprise Value693.50M

Share Statistics

Genpharmasec Ltd. currently has 553.72M shares outstanding.

Shares Outstanding553.72M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Genpharmasec Ltd. trades at a trailing price-to-earnings ratio of 55.26. The price-to-sales ratio is 0.33, and the price-to-book ratio stands at 0.83.

PE Ratio55.26
PS Ratio0.33
PB Ratio0.83
P/TBV Ratio0.97
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Genpharmasec Ltd. trades at an EV/EBITDA multiple of 994.87 and an EV/FCF ratio of 96.90. The EV/Sales ratio of 0.50 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 994.87 provides insight into valuation relative to core operating earnings.

EV / Sales0.50
EV / EBITDA994.87
EV / EBIT994.87
EV / FCF96.90

Financial Position

Genpharmasec Ltd. maintains a current ratio of 1.71, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 53.24, indicating elevated leverage, while an interest coverage ratio of -0.76 demonstrates limited ability to service its debt obligations.

Current Ratio1.71
Quick Ratio0.23
Debt / Equity53.24
Debt / EBITDA-36.93
Interest Coverage-0.76

Financial Efficiency

Genpharmasec Ltd. posts a return on equity of 1.55 and a return on invested capital of -0.63.

Return on Equity (ROE)1.55
Return on Assets (ROA)0.76
Return on Invested Capital (ROIC)-0.63
Return on Capital Employed (ROCE)2.48
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover11.61

Taxes

Over the trailing twelve months, Genpharmasec Ltd. has paid 4.11M in income taxes, reflecting an effective tax rate of 42.30.

Income Tax4.11M
Effective Tax Rate42.30

Stock Price Statistics

Genpharmasec Ltd.'s stock has declined approximately -44.05941% over the past 52 weeks. The 50-day moving average sits at 1.17, while the 200-day moving average is 1.33.

Beta (5Y)N/A
52-Week Price Change-44.05941%
50-Day Moving Average1.17
200-Day Moving Average1.33
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Genpharmasec Ltd. generated 1.40B in revenue and converted that into 8.34M in net income, yielding earnings per share of 0.01. EBITDA reached -9.46M, while operating income came in at -9.46M.

Revenue1.40B
Gross Profit118.32M
Operating Income-9.46M
Pretax Income9.71M
Net Income8.34M
EBITDA-9.46M
EBIT-9.46M
Earnings Per Share (EPS)0.01

Balance Sheet

Genpharmasec Ltd. holds 110.42M in cash and equivalents against 349.47M in total debt, resulting in a net debt position of 320.03M. Total book value stands at 553.72M, with working capital of 334.96M providing operational flexibility.

Cash & Cash Equivalents110.42M
Total Debt349.47M
Net Debt320.03M
Equity (Book Value)553.72M
Book Value Per Share0.94
Working Capital334.96M

Margins

Genpharmasec Ltd. operates with a gross margin of 8.46, reflecting its pricing power and cost economics. The operating margin of -0.68 and net profit margin of 0.60 provide insight into operational efficiency.

Gross Margin8.46
Operating Margin-0.68
Pretax Margin0.69
Profit Margin0.60
EBITDA Margin-0.68

Stock Splits

Genpharmasec Ltd.'s most recent stock split took place on April 11, 2019 with a 1:10 split ratio.

Last Split Date4/11/2019
Split Ratio1:10

Scores

Genpharmasec Ltd. posts an Altman Z-Score of 1.86, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.86